ArticleInternational journal of legal medicine2026
Developmental validation of the rapidpuncher, an automated laser-based sampling system that eliminates cross-contamination in the forensic analysis of FTA cards.
Article in International journal of legal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The rapidPuncher is an advanced, fully automated laser sampling system designed for forensic and diagnostic genetic laboratories, enabling precise disc-shaped sample cutting from FTA cards (by burning a ring) for DNA extraction. Its laser cutting method eliminates physical contact, which solves the long-standing problem of possible cross-contamination that comes with traditional mechanical punching tools. This study provides developmental validation of the rapidPuncher, encompassing evaluations of linearity, cross-contamination risk, and efficacy in STR and mtDNA profiling. Validation tests using blood, buccal swabs, and saliva on FTA media showed that the platform allows for precise, contamination-free sample excision. The DNA yields and quality were similar to those of traditional sample preparation, and the STR and mtDNA profiles were always reliable. The integrated vision system automates the process of identifying high biological material saturation sites, which facilitates reproducibility. Comparative testing confirmed no significant transfer of DNA to blank FTA cards. The rapidPuncher complies with ISO/IEC 17025 and ISO/IEC 21043 standards for forensic laboratory practice and greatly improves the automation of laboratory workflows, reduces the risk of human error, and ensures high accuracy for forensic casework and molecular diagnostics.
Indexed as
Identifiers
42554786What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.